Factors Affecting Influenza and Pneumococcal Vaccination Rates in Hemodialysis Patients: A Multicenter Study

Factors Affecting Influenza and Pneumococcal Vaccination Rates in Hemodialysis Patients: A Multicenter Study

Tamer Selen,1 Özgür Merhametsiz,2 Kür&scedil;ad Öneç,3 Zafer Ercan,4 Mahmud &Idot;slam,4 Gül&scedil;ah Altun,3 Musa P&inodot;nar,4 Mehmet Emin Demir5 1Nephrology Department, Düzce Atatürk State Hospital, Düzce, Turkey; 2Nephrology Department, Yeniyüzy&inodot;l University Private...

Full description

Saved in:

Bibliographic Details
Main Authors:	Selen T, Merhametsiz Ö, Öneç K, Ercan Z, İslam M, Altun G, Pınar M, Demir ME
Format:	Article
Language:	English
Published:	Dove Medical Press 2025-01-01
Series:	Risk Management and Healthcare Policy
Subjects:	hemodialysis influenza pneumococcal pneumonia vaccine
Online Access:	https://www.dovepress.com/factors-affecting-influenza-and-pneumococcal-vaccination-rates-in-hemo-peer-reviewed-fulltext-article-RMHP
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A population-based study on the burden of hospitalized pediatric pneumococcal disease in Taiwan before and after the introduction of 13-valent pneumococcal conjugate vaccine into the childhood immunization program in 2015
by: Ting-An Yen, et al.
Published: (2025-02-01)

Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based survey
by: Youngju Kim, et al.
Published: (2025-12-01)

Impact of invasive and noninvasive pneumococcal diseases on adult populations: risk factors and vaccination status
by: Hasip Kahraman, et al.
Published: (2025-02-01)

Establishing a new human pneumococcal standard reference serum, MPRSS-01
by: Joseph M. Antonello, et al.
Published: (2025-01-01)

Implementation of a Targeted Technologic Screening Tool to Increase Pneumococcal Vaccine Uptake in Health-System Retail Pharmacies: A Quality Improvement Initiative
by: Annika Skogg, et al.
Published: (2024-12-01)

Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months of age: a randomized controlled study
by: Alane Izu, et al.
Published: (2025-12-01)

Influencing factors for influenza vaccination among the elderly
by: LI Yiyao, LI Xiaoju, SHEN Xiaoying, ZHANG Xianqi, ZHAO Li, ZHANG Yuhan, WANG Xinmeng
Published: (2025-01-01)

A case of vaccine‐associated myocarditis following pneumococcal immunization leading to acute mitral regurgitation
by: Hiroyuki Yamamoto, et al.
Published: (2022-06-01)

Evaluating Families’ Opinions of Routine Influenza Vaccination in Children Under 5 Years of Age in Spain
by: Sílvia Burgaya-Subirana, et al.
Published: (2025-01-01)

Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children
by: Stephanie A. Davey, et al.
Published: (2025-12-01)

Vaccine effectiveness against influenza-associated hospitalizations in adults with liver disease, 2015–2020: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)
by: Po-Han Huang, et al.
Published: (2025-12-01)

Influenza Vaccination Rates, Perceptions, and Vaccine Hesitancy in K-12 Teachers and Staff
by: Kevin Cleveland, et al.
Published: (2025-02-01)

Intracranial complications in adult patients with severe pneumococcal meningitis: a retrospective multicenter cohort study
by: Camille Legouy, et al.
Published: (2024-12-01)

Optimal control of vaccination dynamics during an influenza epidemic
by: Majid Jaberi-Douraki, et al.
Published: (2014-05-01)

Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine
by: Yongqiang Zhao, et al.
Published: (2025-02-01)

Epidemic Analysis and Mathematical Modelling of Influenza with Vaccination.
by: Musiime, Catherine
Published: (2024)

Epidemic Analysis and Mathematical Modelling of Influenza with Vaccination
by: Musiime, Catherine
Published: (2022)

The Development of a Novel Broad-Spectrum Influenza Polypeptide Vaccine Based on Multi-Epitope Tandem Sequences
by: Song Zhao, et al.
Published: (2025-01-01)

The Saudi thoracic society guidelines for vaccinations in adult patients with chronic respiratory diseases
by: Mohammed Al Ghobain, et al.
Published: (2025-01-01)

Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us?
by: Iván Sanz-Muñoz, et al.
Published: (2025-02-01)

Estimation of invasive pneumococcal disease dynamics parameters and the impact of conjugate vaccination in Australia
by: Karyn L. Sutton, et al.
Published: (2007-12-01)

Relationship between influenza-related experience and current vaccination outcome
by: Yunwei Gai
Published: (2025-01-01)

Optimal strategies of social distancing and vaccination against seasonal influenza
by: Eunha Shim
Published: (2013-07-01)

Prioritization of delayed vaccination for pandemic influenza
by: Eunha Shim
Published: (2010-12-01)

A note on the use of influenza vaccination strategies when supply is limited
by: Sunmi Lee, et al.
Published: (2010-12-01)

Impaired Hepatitis B and COVID-19 vaccination responses show strong concordance in hemodialysis patients with end stage renal disease
by: Karsten Lürken, et al.
Published: (2025-01-01)

Seasonal Influenza Vaccination Uptake Among Australian Healthcare Professionals: An Archetype for Success
by: Caroline M. Hall, et al.
Published: (2025-01-01)

Positive real-time PCR in pneumococcal meningitis 12 hours after initiation of antibiotic therapy – case report
by: Cem Thunstedt, et al.
Published: (2025-01-01)

Rapid Verbal Persuasion to increase influenza vaccine uptake: protocol for a randomized hybrid type 2 effectiveness -implementation trial
by: Siyuan Liu, et al.
Published: (2025-02-01)

Assessing the impact of educational methods on influenza vaccine uptake and patient knowledge and attitudes: a randomised controlled trial
by: Pei Lin Hu, et al.
Published: (2023-02-01)

Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza in elderly Chinese patients with diabetes: A test-negative design case-control study
by: Zhengyan Chen, et al.
Published: (2025-12-01)

Evaluation of humoral immune response and milk antibody transfer in calves and lactating cows vaccinated with inactivated H5 avian influenza vaccine
by: Mohamed Samy Abousenna, et al.
Published: (2025-02-01)

Attitudes Toward General Vaccination Mediate the Association Between Influenza Vaccination History and Pneumococcal Vaccination Intention Among Older Adults in China
by: Siwen Huang, et al.
Published: (2024-12-01)

Evaluation of Influenza Vaccine Effectiveness from 2021 to 2024: A Guangdong-Based Test-Negative Case–Control Study
by: Liyan Zhu, et al.
Published: (2024-12-01)

Optimal individual strategies for influenza vaccines with imperfect efficacy and durability of protection
by: Francesco Salvarani, et al.
Published: (2018-05-01)

Anti-pneumococcal vaccination in Cuba. Challenges
by: Dunia María Chávez Amaro, et al.
Published: (2019-02-01)

Sociodemographic disparities in influenza vaccination among older adults in United States
by: Huan Tao, et al.
Published: (2025-02-01)

Unveiling unique effector function-related bulk antibody profiles in long-term hemodialysis patients following COVID-19 mRNA booster vaccination
by: Chia-Yi Chou, et al.
Published: (2025-02-01)

Comparative testing of vaccines based on viruses of genetic lineages G1 and Y280 for their potency against low pathogenic avian influenza H9N2
by: S. V. Frolov, et al.
Published: (2021-08-01)

Critical assessment of uncertainty in economic evaluations on influenza vaccines for the elderly population in Spain
by: Raúl Ortiz-de-Lejarazu Leonardo, et al.
Published: (2025-02-01)